NEW ORLEANS (June 23, 2025)—A novel PET radiotracer can accurately detect a wide range of mold species that are linked to dangerous infections, according to new research presented at the Society of Nuclear Medicine and Molecular Imaging 2025 Annual Meeting. The imaging agent has the potential to dramatically enhance the diagnosis and monitoring of invasive mold infections in patients.
Advances in cancer and immunosuppressive treatments have helped many patients live longer, but they also leave more people with weakened immune systems, making invasive mold infections increasingly common. With mortality rates of invasive mold infections reaching up to 85 percent, early and accurate diagnosis followed by timely treatment is critical to improving patient outcomes.
"Currently it's very difficult to detect invasive mold infections," said Carlos Ruiz-Gonzalez, MD, a postdoctoral research fellow at Johns Hopkins University Medical School in Baltimore, Maryland. "Definitive diagnosis often depends on invasive procedures or on biomarkers that lack sensitivity for many mold species. In this study, we aimed to develop a PET tracer capable of detecting a broad range of mold infections and distinguishing them from inflammation with high sensitivity and specificity."
The imaging agent, 18F-FDS, was first evaluated in vitro to determine its ability to detect 30 different strains of disease-causing molds collected from infected patients. 18F-FDS PET/CT was then performed to identify fungal infections in mice with weakened immune systems, as well as in four human patients with confirmed invasive mold infections, and five control patients with inflammatory diseases or cancer, but no infections.
18F-FDS was found to quickly and specifically accumulate inside a wide range of disease-causing molds (including drug-resistant strains) while showing no uptake in heat-killed molds or human cells. Among mice, it accurately identified fungal infections in the lungs, brain, and sinuses, and was able to distinguish these from non-infectious inflammation. In patient studies, 18F-FDS PET safely detected and localized mold infections—including one missed by a previous brain MRI.
"This research demonstrates that 18F-FDS PET is a promising, noninvasive diagnostic tool to detect mold-related invasive fungal diseases," noted Ruiz-Gonzalez. "What's more, since 18F-FDS can be easily produced from 18F-FDG, it can be synthesized on demand and made available globally. This can have a real impact for patients around the world."
Abstract 252079. "18F-Fluorodeoxysorbitol PET for noninvasive detection of invasive mold infections in patients," Carlos Ruiz-Gonzalez, Oscar Nino-Meza, Medha Singh, Yuderleys Masias-Leon, Amy Kronenberg, Madelyn Shamble, Xueyi Chen, Mona Sarhan, Elizabeth Tucker, Laurence Carroll, Kenneth Cooke, Olivia Kates, Shmuel Shoham, Sean Zhang, and Sanjay Jain, Johns Hopkins University School of Medicine, Baltimore, Maryland.
